Genprex, Inc.
General ticker "GNPX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $369.1M (TTM average)
Genprex, Inc. does not follow the US Stock Market performance with the rate: -10.4%.
Estimated limits based on current volatility of 5.1%: low 2.86$, high 3.17$
Factors to consider:
- Total employees count: 26 (-7.1%) as of 2023
- Top business risk factors: Insufficient funding, Going concern, Geopolitical risks, Intellectual property risks, Strategic risks and growth management
- Current price 85.6% below estimated low
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [58.24$, 310.43$]
- 2024-12-30 to 2025-12-30 estimated range: [23.31$, 119.63$]
Financial Metrics affecting the GNPX estimates:
- Negative: with PPE of -19.3 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -206.25 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Negative: negative Industry operating income (median)
- Negative: -0.75 < Inventory ratio change, % of 0
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
Short-term GNPX quotes
Long-term GNPX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $20.67MM | $23.83MM | $31.08MM |
| Operating Income | $-20.67MM | $-23.83MM | $-31.08MM |
| Non-Operating Income | $0.01MM | $0.09MM | $0.22MM |
| R&D Expense | $8.97MM | $11.51MM | $17.62MM |
| Income(Loss) | $-20.66MM | $-23.74MM | $-30.86MM |
| Profit(Loss)* | $-21.74MM | $-23.74MM | $-30.86MM |
| Stockholders Equity | $41.28MM | $22.27MM | $7.42MM |
| Assets | $42.86MM | $25.09MM | $10.67MM |
| Operating Cash Flow | $-14.28MM | $-17.62MM | $-24.74MM |
| Capital expenditure | $0.08MM | $0.00MM | $0.07MM |
| Investing Cash Flow | $-0.08MM | $-0.06MM | $-0.07MM |
| Financing Cash Flow | $25.68MM | $0.01MM | $10.59MM |
| Earnings Per Share** | $-923.51 | $-990.84 | $-1,128.77 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.